Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression.
about
Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy.MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.Leinal polypeptide promotes NK cells to suppress PCa survival in vitro.Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.Carcinogenesis in prostate cancer: The role of long non-coding RNAsEnzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
P2860
Q47307286-1A148223-85C6-446A-86B0-37F1E451AEB1Q50354652-E519DCD3-7446-46AB-84C1-66A5965A8B11Q54936175-A4C40294-9497-4EA6-83B3-BAA096429C4CQ55298969-E018FC7C-E143-47A0-9D06-BE69C1EB45E9Q55331819-470B0018-606D-47F3-BE8A-3B83AE2CADE2Q55356724-4F6D1CBA-B9A5-4C2F-8967-4457FD521D63Q57114753-A86F33F4-A89E-4BF9-A5DE-FB86E901CDFAQ58698705-CCD2FC06-7C88-47FC-AD85-E9F51EC8A4A7
P2860
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Preclinical Study using Malat1 ...... t Prostate Cancer Progression.
@en
type
label
Preclinical Study using Malat1 ...... t Prostate Cancer Progression.
@en
prefLabel
Preclinical Study using Malat1 ...... t Prostate Cancer Progression.
@en
P2093
P2860
P1433
P1476
Preclinical Study using Malat1 ...... t Prostate Cancer Progression.
@en
P2093
Changyi Lin
Chawnshang Chang
Emmanuel S Antonarakis
Ronghao Wang
Shuyuan Yeh
Wanying Lin
Yuanjie Niu
P2860
P304
P356
10.1016/J.EURURO.2017.04.005
P407
P577
2017-05-18T00:00:00Z